Hyperbaric oxygen on rehabilitation of brain tumors after surgery and effects on TNF-α and IL-6 levels

Hou,Shicai; Wu,Guimei; Liang,Jingjing; Cheng,Huanchun; Chen,Chao

doi:10.3892/ol.2019.10000

Hyperbaric oxygen on rehabilitation of brain tumors after surgery and effects on TNF-α and IL-6 levels

Authors:
- Shicai Hou
- Guimei Wu
- Jingjing Liang
- Huanchun Cheng
- Chao Chen
View Affiliations

Affiliations: Department of Rehabilitation, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Department of Neurosurgery (Ward 1), People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Department of Pediatrics (III), People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China, Department of Surgery, Xujiahu Health Center, Linyi, Shandong 276400, P.R. China
Published online on: January 31, 2019 https://doi.org/10.3892/ol.2019.10000
Pages: 3277-3282
Copyright: © Hou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyperbaric oxygenation (HBO) on postoperative rehabilitation of brain tumors and effects on tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels were explored. A retrospective analysis of 132 patients with brain tumors treated in the People's Hospital of Rizhao from October 2014 to October 2017 was performed. There were 62 patients in the observation group and 70 patients in the control group. Patients in the control group were treated with conventional drugs, and patients in the observation group were treated with HBO on the basis of conventional drug therapy. Levels of serum TNF-α and IL-6 were measured by ELISA before and after treatment. Cerebral arterial flow velocity and spasticity were measured by cranial color Doppler ultrasonography. Neurological function deficit (NFD) and activities of daily living (ADL) were used to evaluate the clinical recovery of the patients. Clinical efficacy was compared and analyzed. There were no significant differences between the two groups before treatment (P>0.05). After treatment, serum TNF-α and IL-6 levels were significantly lower than pretreatment levels (P<0.05), and serum TNF-α and IL-6 levels in the observation group were lower than those in the control group (P<0.05). Cerebral arterial flow velocity in observation group after treatment was significantly lower than that in the control group. The number of patients with cerebral arterial spasm after treatment in the observation group was significantly smaller than that in the control group. NFD scores in the observation group were lower than those in the control group after treatment. After treatment, ADL scores in the observation group were significantly higher than those in the control group (P<0.05). The comprehensive treatment effect of HBO is significant. It can inhibit the expression of inflammatory factors in serum and reduce cerebral arterial flow velocity and effectively reduce the number of patients with cerebral arterial spasm. It can reduce NFD and improve the quality of life of patients. Therefore, it is worthy of clinical popularization.

View Figures

View References

1	Sonoda J and Wharton RP: Drosophila Brain Tumor is a translational repressor. Genes Dev. 15:762–773. 2001. View Article : Google Scholar : PubMed/NCBI
2	Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, et al: A perivascular niche for brain tumor stem cells. Cancer Cell. 11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
3	Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, et al: Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 6:553–563. 2004. View Article : Google Scholar : PubMed/NCBI
4	Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, et al: Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6:e10000292009. View Article : Google Scholar : PubMed/NCBI
5	Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, et al: A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med. 18:829–834. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, et al: Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer 113 (Suppl). 1953–1968. 2008. View Article : Google Scholar
7	Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B and Novikov I: Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res. 163:424–432. 2005. View Article : Google Scholar : PubMed/NCBI
8	Marois P: Hyperbaric oxygen treatment. Ann Neurol. 74:1492013. View Article : Google Scholar : PubMed/NCBI
9	Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, Adachi G, Iraha S, Tamaki W, Sugimoto K, et al: Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Br J Cancer. 95:862–868. 2006. View Article : Google Scholar : PubMed/NCBI
10	Luna-Oliva L, Ortiz-Gutiérrez RM, Cano-de la Cuerda R, Piédrola RM, Alguacil-Diego IM, Sánchez-Camarero C and Martínez Culebras Mdel C: Kinect Xbox 360 as a therapeutic modality for children with cerebral palsy in a school environment: A preliminary study. NeuroRehabilitation. 33:513–521. 2013.PubMed/NCBI
11	McIntyre S, Taitz D, Keogh J, Goldsmith S, Badawi N and Blair E: A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol. 55:499–508. 2013. View Article : Google Scholar : PubMed/NCBI
12	Nordberg A, Miniscalco C, Lohmander A and Himmelmann K: Speech problems affect more than one in two children with cerebral palsy: Swedish population-based study. Acta Paediatr. 102:161–166. 2013. View Article : Google Scholar : PubMed/NCBI
13	Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A and Eberhart CG: Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 64:7787–7793. 2004. View Article : Google Scholar : PubMed/NCBI
14	Schneweis S, Grond M, Staub F, Brinker G, Neveling M, Dohmen C, Graf R, Heiss WD and Shuaib A: Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke. 32:1863–1867. 2001. View Article : Google Scholar : PubMed/NCBI
15	Zhao YP, Zhang YQ, Duan HY, Ma Y, Liang H, Zhang QH, Xue CQ, Luo B and Pan X: Intracranial mixed germ cell tumor. Zhonghua Yi Xue Za Zhi. 97:661–665. 2017.(In Chinese). PubMed/NCBI
16	Tian L, Lin Q and Zhang J: To explore the community rehabilitation assessment scales for patients with stroke sequelae. Glob J Cardiovasc Cerebrovasc Dis. 3:16–20. 2015.
17	Kranke P, Bennett M, Roeckl-Wiedmann I and Debus S: Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 14:CD0041232004.
18	Bennett MH, Feldmeier J, Hampson N, Smee R and Milross C: Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 5:CD0050052005.
19	Thom SR: Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. N Engl J Med. 347:1105–1106. 2002. View Article : Google Scholar : PubMed/NCBI
20	Yin W, Badr AE, Mychaskiw G and Zhang JH: Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res. 926:165–171. 2002. View Article : Google Scholar : PubMed/NCBI
21	Palzur E, Vlodavsky E, Mulla H, Arieli R, Feinsod M and Soustiel JF: Hyperbaric oxygen therapy for reduction of secondary brain damage in head injury: An animal model of brain contusion. J Neurotrauma. 21:41–48. 2004. View Article : Google Scholar : PubMed/NCBI
22	Chen LF, Tian YF, Lin CH, Huang LY, Niu KC and Lin MT: Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia. J Formos Med Assoc. 113:620–628. 2014. View Article : Google Scholar : PubMed/NCBI
23	Schellart NA, Reits D, van der Kleij AJ and Stalpers LJ: Hyperbaric oxygen treatment improved neurophysiologic performance in brain tumor patients after neurosurgery and radiotherapy: A preliminary report. Cancer. 117:3434–3444. 2011. View Article : Google Scholar : PubMed/NCBI
24	Xu WZ: Clinical effect of hyperbaric oxygen therapy in patients with brain tumor and cerebral aneurysm. Chin J Practical Nervous Diseases. 20:61–62. 2017.
25	Lim SW, Wang CC, Wang YH, Chio CC, Niu KC and Kuo JR: Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy. J Surg Res. 184:1076–1084. 2013. View Article : Google Scholar : PubMed/NCBI
26	Lin L: Effectiveness of postoperative hyperbaric oxygen interventional therapy for patients with brain tumor and cerebral aneurysm. Chin J General Practice. 11:684–685. 2013.